Western Securities Co.Ltd(002673) maintain the Qingdao Novelbeam Technology Co.Ltd(688677) buy rating. Comments on the 2021 annual report and the first quarter report of 2022: the performance meets the expectations, and the whole machine system is expected to bring performance increment

Western Securities Co.Ltd(002673) 04 released a research report on April 25, saying that it maintained the buying rating of Qingdao Novelbeam Technology Co.Ltd(688677) ( Qingdao Novelbeam Technology Co.Ltd(688677) .sh, latest price: 72.55 yuan). The reasons for rating mainly include: 1) the R & D expense rate has increased significantly, and the net interest rate shows an upward trend; 2) The company actively carries out the development, registration and industrialization of endoscope light source system and camera system. Risk warning: industry competition intensifies the risk; Covid-19 epidemic development uncertainty risk; Industry policy risk; R & D is less than expected risk; Medical malpractice risk;

AI comments: Qingdao Novelbeam Technology Co.Ltd(688677) in the past month, it has received four research reports from securities companies and bought four.

- Advertisment -